DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Clinician-vetted GLP-1 options for Illinois residents managing weight loss. Coverage carriers, state-specific telehealth eligibility, and in-state pharmacy pricing notes.
Illinois has a population of 12,549,689 and ranks among US states for weight loss prevalence. Below: the 5 highest-scoring GLP-1 medications based on our editorial methodology, with Illinois-specific notes on insurance coverage and telehealth provider availability.

Obesity-medicine telehealth that takes insurance

FDA-approved tirzepatide for weight loss

Tirzepatide for type 2 diabetes

FDA-approved semaglutide for chronic weight management

Eli Lilly oral tirzepatide for weight loss (Apr 2026 launch)
Coverage decisions depend on your specific plan, employer formulary, and prior-auth requirements. Illinois residents commonly hold plans through Blue Cross Blue Shield of Illinois, Aetna, Cigna, UnitedHealthcare, Humana, and Kaiser Permanente (where available). Each carrier handles GLP-1 prior auth and step therapy differently.
Check our coverage matrix for current Illinois carrier × drug coverage data, refreshed monthly.
Most major telehealth providers (Ro, Form Health, Hims) operate in Illinois. Specific telehealth rules — particularly for compounded semaglutide and tirzepatide — vary. Some compounded routes are unavailable in Illinois due to state-specific telehealth prescribing rules. Verify the provider lists Illinois as a service state before signing up.
LoseLab ranks medications using a weighted rubric: clinical efficacy (40%), safety profile (25%), cost transparency (20%), and access (15%). Rankings are reviewed by board-certified clinicians and updated monthly. We do not adjust ranking based on commercial relationships. Read full methodology.